Viewing Study NCT01622101



Ignite Creation Date: 2024-05-06 @ 12:40 AM
Last Modification Date: 2024-10-26 @ 10:52 AM
Study NCT ID: NCT01622101
Status: COMPLETED
Last Update Posted: 2012-06-21
First Post: 2012-06-14

Brief Title: Thermogenic Properties of Zantrex-3
Sponsor: University of Copenhagen
Organization: University of Copenhagen

Study Overview

Official Title: Acute Effects of Zantrex-3 on Energy Expenditure and Appetite Sensations
Status: COMPLETED
Status Verified Date: 2012-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ZANTREX
Brief Summary: Background Zantrex-3 is a popular dietary supplement for weight control which consists of a combination of yerba mate guarana caffeine and damiana The combination has previously been shown to decrease gastric emptying and its weight controlling effects may be related to increased satiety and thermogenesis

Objective To investigate the effect of Zantrex-3 on energy expenditure hemodynamic factors and subjective appetite sensations

Design Twenty-three men BMI 23932 kgm2 meanSD participated in a randomized double-blind placebo-controlled crossover study The Zantrex-3 compound contained 365 mg xantines caffeine and caffeine-like stimulants yerba mate guarana and damiana The thermogenic effect was measured for 3 hours post-intake Blood pressure BP heart rate HR and appetite ratings were assessed every half hour
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None